Mono-menotropins Versus rFSH Protocol on Embryo Quality
Status:
Completed
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
This study is for couples pursuing in vitro fertilization (IVF) with preimplantation genetic
screening (PGS) of embryos to achieve pregnancy. The objective of this clinical trial is to
study the effect of mono-menotropins for COS versus recombinant follicle stimulating hormone
(rFSH) on cleavage-stage and blastocyst embryo quality after IVF. Embryo quality parameters
include conventional embryo grade, early embryo viability assessment (Eeva) time-lapse
parameters, and chromosomal aneuploidy rates after PGS.
This pilot study is expected to significantly contribute to optimization of treatment
regimens and stimulation protocols to optimize embryo quality.